Tocilizumab for the Critically Ill With Severe COVID-19: A Community Hospital Case Series.

Objective: To evaluate the use of tocilizumab in a community hospital setting for critically ill patients with severe COVID-19.

Design: A retrospective case series.

Setting: Five community hospitals within 1 urban health system.

Sensitizing the interdisciplinary team to desensitizations: An alemtuzumab case report.

Introduction: We describe a case of alemtuzumab (Campath®) hypersensitivity requiring desensitization within the medical intensive care unit (MICU) in a patient with T-cell prolymphocytic leukemia.

Case Report: We adopted a desensitization protocol from Gutierrez-Fernandez et al., which included three aliquots (0.

Interplay of personal, pet, and environmental colonization in households affected by community-associated methicillin-resistant Staphylococcus aureus.

Objective: We sought to determine the prevalence, molecular epidemiology, and factors associated with Staphylococcus aureus environmental surface and pet colonization in households of children with community-associated methicillin-resistant S. aureus (CA-MRSA) infection.

Methods: Between 2012 and 2015, 150 children with CA-MRSA infections and their household contacts and pets were enrolled in this cross-sectional study in metropolitan Saint Louis, MO.